For: | Malemud CJ, Blumenthal DE. Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives. World J Orthop 2014; 5(4): 496-503 [PMID: 25232525 DOI: 10.5312/wjo.v5.i4.496] |
---|---|
URL: | https://www.wjgnet.com/2218-5836/full/v5/i4/496.htm |
Number | Citing Articles |
1 |
Kaue Franco Malange, Juliana M. Navia-Pelaez, Elayne Vieira Dias, Julia Borges Paes Lemes, Soo-Ho Choi, Gilson Goncalves Dos Santos, Tony L. Yaksh, Maripat Corr. Macrophages and glial cells: Innate immune drivers of inflammatory arthritic pain perception from peripheral joints to the central nervous system. Frontiers in Pain Research 2022; 3 doi: 10.3389/fpain.2022.1018800
|
2 |
Yuxuan Chen, Qingya Du, Mengtian Xi. Exploring New Therapeutic Approaches for Rheumatoid Arthritis Based on Basic Signaling Pathways. Highlights in Science, Engineering and Technology 2023; 54: 150 doi: 10.54097/hset.v54i.9750
|
3 |
Nimmish Khera, Sandeep Rajput. Therapeutic Potential of Small Molecule Inhibitors. Journal of Cellular Biochemistry 2017; 118(5): 959 doi: 10.1002/jcb.25782
|
4 |
Charles J. Malemud. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy. Progress in Molecular Biology and Translational Science 2017; 148: 305 doi: 10.1016/bs.pmbts.2017.03.003
|
5 |
Jihye Yoo, Darong Kim, Jiyoung Park, Young-Kook Kim, Hea-Young Park Choo, Hyun Ae Woo. Novel Small Molecule Inhibitors Targeting the IL-6/STAT3 Pathway or IL-1β. Molecules 2022; 27(9): 2696 doi: 10.3390/molecules27092696
|
6 |
Yuhao Wang, Benjamin Bonavida. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. 2021; : 311 doi: 10.1016/B978-0-12-821909-6.00018-3
|
7 |
Charles Malemud. Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis. International Journal of Molecular Sciences 2017; 18(3): 484 doi: 10.3390/ijms18030484
|
8 |
Charles J. Malemud. The role of the JAK/STAT signal pathway in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease 2018; 10(5-6): 117 doi: 10.1177/1759720X18776224
|
9 |
Muhammad Safwan Akram, Neelam Pery, Lucy Butler, Muhammad Imtiaz Shafiq, Nayab Batool, Muhammad Fayyaz ur Rehman, Luke G. Grahame-Dunn, Ali K. Yetisen. Challenges for biosimilars: focus on rheumatoid arthritis. Critical Reviews in Biotechnology 2021; 41(1): 121 doi: 10.1080/07388551.2020.1830746
|